NASDAQ · SXTC
Healthcare · Drug Manufacturers - Specialty & Generic
$3.68
Up+$0.13 (+3.66%)
Updated Oct 29, 2026, 1:06 PM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · SXTC
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 28, 2026
SXTC closed at $3.68 after 21 trading sessions, up 22.26% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 28, 2026 | $3.81 | $3.8297 | $3.4601 | $3.68 | 172.47K |
| Oct 27, 2026 | $3.47 | $4.07 | $3.28 | $3.55 | 237.05K |
| Oct 26, 2026 | $4.15 | $4.2307 | $3.37 | $3.54 | 204.98K |
| Oct 23, 2026 | $4.21 | $4.55 | $3.81 | $4.10 | 227.41K |
| Oct 22, 2026 | $5.10 | $5.14 | $4.51 | $4.80 | 574.89K |
| Oct 21, 2026 | $7.32 | $9.22 | $6.60 | $7.30 | 2.3M |
| Oct 20, 2026 | $6.54 | $7.00 | $6.30 | $6.53 | 526.78K |
| Oct 19, 2026 | $0.0634 | $0.1227 | $0.0611 | $0.1112 | 88.06M |
| Oct 16, 2026 | $0.0818 | $0.0818 | $0.0621 | $0.065 | 263.85M |
| Oct 15, 2026 | $0.0629 | $0.071 | $0.0619 | $0.0688 | 62.49M |
| Oct 14, 2026 | $0.0688 | $0.0733 | $0.0627 | $0.0685 | 33.51M |
| Oct 13, 2026 | $0.0802 | $0.0838 | $0.0659 | $0.0774 | 59.63M |
| Oct 12, 2026 | $0.10 | $0.1122 | $0.091 | $0.102 | 82.69M |
| Oct 9, 2026 | $0.2365 | $0.24 | $0.1233 | $0.1487 | 116.28M |
| Oct 8, 2026 | $0.46 | $0.4643 | $0.31 | $0.3435 | 64.91M |
| Oct 7, 2026 | $3.19 | $9.59 | $1.87 | $2.83 | 146.57M |
| Oct 6, 2026 | $2.04 | $2.06 | $1.18 | $1.25 | 9.55M |
| Oct 5, 2026 | $2.31 | $2.44 | $1.54 | $2.08 | 950.46K |
| Oct 2, 2026 | $3.00 | $3.09 | $1.941 | $2.41 | 779.92K |
| Oct 1, 2026 | $3.02 | $3.27 | $2.91 | $2.96 | 299.67K |
| Sep 30, 2026 | $2.79 | $3.10 | $2.76 | $3.01 | 192.47K |
The latest Smart Investors Daily articles mentioning SXTC.
Company
Market Activity
Research & News
SXTC research
Company profile and research snapshot.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Oct 8, 2026
China SXT Pharmaceuticals Inc. (NASDAQ:SXTC) (the "Company"), today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale of an aggregate
Benzinga · Feb 2, 2026
Benzinga · Feb 2, 2026
Yahoo · Jan 15, 2026
TAIZHOU, China, Jan. 15, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced as part of its Artificial Intelligence (AI) Insight
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning SXTC.
